Showing results (151-160 of 25,160) with videos related to

Sort By:
Pageof 2,516
Oncotarget|August 4, 2016
Intratumoral heterogeneity of the therapeutical response to gemcitabine and metforminDietmar Zechner, Florian Bürtin, Ann-Christin Albert, et al.
Oncotarget|August 4, 2016
Radio-frequency plasma polymerized biodegradable carrier for in vivo release of cis-platinumSudhir Bhatt, Fatemeh Valamanesh, Jerome Pulpytel, et al.
Oncotarget|August 4, 2016
Samarium-153-EDTMP (Quadramet®) with or without vaccine in metastatic castration-resistant prostate cancer: A randomized Phase 2 trialChristopher R Heery, Ravi A Madan, Mark N Stein, et al.
Oncotarget|August 4, 2016
TAM receptors Tyro3 and Mer as novel targets in colorectal cancerRobin Schmitz, Aida Freire Valls, Rosario Yerbes, et al.
Oncotarget|August 4, 2016
Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastomaWei Jiang, Susan Finniss, Simona Cazacu, et al.
Oncotarget|August 4, 2016
The lncRNA MALAT1 is a novel biomarker for gastric cancer metastasisHongwei Xia, Qingjuan Chen, Ying Chen, et al.
Oncotarget|August 4, 2016
Predictive value of pedicle involvement with MRI in spine metastasesWang Mi Liu, Rong Xing, Chong Bian, et al.
Oncotarget|August 4, 2016
The effect of radiotherapy in liver-confined but non-resectable Barcelona Clinic Liver Cancer stage C large hepatocellular carcinomaHong In Yoon, Inkyung Jung, Kwang-Hyub Han, et al.
Oncotarget|August 4, 2016
Occult HBV infection in HCC and cirrhotic tissue of HBsAg-negative patients: a virological and clinical studyNicola Coppola, Lorenzo Onorato, Valentina Iodice, et al.
Oncotarget|August 4, 2016
Inherent low Erk and p38 activity reduce Fas Ligand expression and degranulation in T helper 17 cells leading to activation induced cell death resistanceDoureradjou Peroumal, Thiruvaimozhi Abimannan, Ravichandra Tagirasa, et al.
Pageof 2,516